The healthcare industry has been in investors’ crosshairs since the onset of the COVID-19 pandemic last year, thanks to its role in helping the world fight the virus. Its momentum should be maintained by massive investments in research and manufacturing of effective therapies for several important diseases. Given the industry’s growth prospects, Wall Street analysts expect the low-priced stocks of budding companies 22nd Century (NASDAQ:), UpHealth (UPH), and Talkspace (TALK) to rally by more than 35% in the near term. So, let’s discuss these names.The discovery of COVID-19 vaccines and drugs, the development of integrated medical diagnostic devices and solutions, virtual consultations, and treatments and therapies for other critical diseases have all helped the healthcare industry grow significantly and garner investor attention. This is evidenced by the Health Care Select Sector SPDR ETF’s (XLV) 20.3% returns over the past year.

Additionally, although large-cap stocks could lose value due to the high level of inflation and volatility, there is a steady demand for health products and services that should support the performance of shares in many other industry sectors.

Given this backdrop, Wall Street analysts are optimistic about the upside potential of budding low-priced stocks in this space—22nd Century Group, Inc. (XXII), UpHealth, Inc. (UPH), and Talkspace, Inc. (TALK). The stocks should see an increase in their price of 35% or more in the immediate future.

Continue reading on StockNews